脑部放疗，上午比下午敏感许多！
; v5 R) ^/ w7 X2 K* y& {& N" e' _! u) `2 X4 L/ F
9 k G, m$ m1 D, C7 h8 LCancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
9 V+ e% g R: ?% E0 Z4 Z6 dGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?6 d+ k% F l$ r9 m
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.9 ]. t+ Z1 @6 Z& K
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.8 D5 w2 P" ~/ Q4 n0 T5 K" U* M/ o
3 i' y! i$ g3 |2 e) l, C q. r
Abstract
' [& k; o) L) A1 T8 j, m' nBACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.: x' V% x. }0 M) X5 A8 R4 ^, H; Y& k
0 } P. s5 n* z) VMETHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
0 z0 b- w9 r9 f- |1 {7 M
8 {& s1 |. \" nRESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).- I. D! D4 k L( s6 @
& C7 R$ b6 X9 f' T( D5 FCONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
* j' l0 |- K1 E' G
E# P2 d' v/ M* R |
( E' k' |+ E! h
显身卡
